Evaluation of diclofenac utilization patterns before and after digital risk minimization intervention in outpatient settings in Montenegro-Reference-Cited by-同舟云学术

Evaluation of diclofenac utilization patterns before and after digital risk minimization intervention in outpatient settings in Montenegro

Published:2024-02 Issue:2 Volume:40 Page:90-100
ISSN:1172-0360
Container-title:Drugs & Therapy Perspectives
language:en
Short-container-title:Drugs Ther Perspect

Author:

Stankovic Maja^ORCID,Turkovic Nemanja,Dobric Silva,Rancic Nemanja

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40267-024-01049-w.pdf

Reference28 articles.

1. European Medicines Agency. Guideline on good pharmacovigilance practices (GVP): module V—risk management systems (Rev 2). 2017. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-good-pharmacovigilance-practices-module-v-risk-management-systems-rev-2_en.pdf. Accessed 15 June 2023.

2. European Medicines Agency. Guideline on good pharmacovigilance practices (GVP): module XVI—risk minimisation measures: selection of tools and effectiveness indicators, draft for public consultation (Rev 3). 2021. https://www.ema.europa.eu/en/human-regulatory/post-authorisation/pharmacovigilance/good-pharmacovigilance-practices. Accessed 15 June 2023.

3. European Medicines Agency. Guideline on good pharmacovigilance practices (GVP): module XVI—risk minimisation measures: selection of tools and effectiveness indicators (Rev 2). 2017. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-good-pharmacovigilance-practices-module-xvi-risk-minimisation-measures-selection-tools_en-3.pdf. Accessed 15 Jun 2023.

4. Ministry of Health of Montenegro. Law on medicines. Official Gazette of Montenegro. 080/2020, 04.08.2020. https://cinmed.me/wp-content/uploads/2022/11/Zakon-o-ljekovima-3.pdf.

5. European Medicines Agency. Assessment report for diclofenac containing medicinal products (systemic formulations), Procedure under Article 31 of Directive 2001/83/EC resulting from pharmacovigilance data. https://www.ema.europa.eu/en/documents/referral/diclofenac-article-31-referral-prac-assessment-report_en.pdf. Accessed 16 June 2023.